Galera Therapeutics (GRTX) says FDA reiterated need for additional Phase 3 trial of avasopasem manganese for radiotherapy-induced SOM streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
31.10.2023 - FDA confirms need for new trial for avasopasem for severe oral mucositis (SOM) GRECO-2 trial did not pass futility analysis; Company will discontinue both GRECO trials Company reviewing potential strategic alternatives to maximize shareholder . Seite 1
U.S. stocks traded lower this morning, following the release of economic reports. Following the market opening Tuesday, the Dow traded down 0.25% to 32,845.12 while the NASDAQ fell 0.50% to 12,726.17. The S&P 500 also fell, dropping, 0.14% to 4,161.09.
U.S. stocks edged lower midway through trading, with the S&P 500 trading slightly lower on Tuesday. The Dow traded down 0.11% to 32,892.75 while the NASDAQ fell 0.23% to 12,760.61. The S&P 500 also fell, dropping, 0.01% to 4,166.81.
U.S. stocks turned higher toward the end of trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.15% to 32,978.85 while the NASDAQ rose 0.20% to 12,814.52. The S&P 500 also rose, gaining, 0.38% to 4,182.85.